Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 92
Filter
Add more filters










Publication year range
1.
Russ J Bioorg Chem ; 49(1): 41-51, 2023.
Article in English | MEDLINE | ID: mdl-37192981

ABSTRACT

Some new polycationic amphiphiles containing a disulfide group were synthesized. Cationic liposomes formed from the compounds synthesized and a helper lipid 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine were not toxic for HEK293 and HeLa cells and were highly effective when delivering a fluorescently labeled oligodeoxyribonucleotide. The efficacy of plasmid DNA delivery depended on the cell line and the amphiphile structure, liposomes based on tetracationic amphiphiles being the most effective transfectants. These liposomes can be used for in vitro transfection of eukaryotic cells as well as for further in vivo biological studies.

2.
Mol Biol (Mosk) ; 54(2): 267-277, 2020.
Article in Russian | MEDLINE | ID: mdl-32392196

ABSTRACT

Melanoma is one of the most aggressive tumors and is accompanied by the induction of local and systemic inflammatory responses. Combinations of chemotherapeutic agents with immunotherapy are therefore commonly used for melanoma treatment. A B16 melanoma model was used to study the tumor suppressive, immunostimulating, and hepatotoxic effects of a combination of a small double-stranded immunostimulatory RNA (isRNA) with 3'-trinucleotide overhangs and the cytotoxic drug dacarbazine compared with respective monotherapies. The drugs efficiently suppressed the tumor growth and acted synergistically. Histological and immunohistochemical examinations of tumor nodes showed that the combination of isRNA and dacarbazine significantly decreased mitotic activity and more efficiently increased apoptosis in tumor tissue as compared with either monotherapy. Regardless of the treatment regimen, signs of immune activation were observed in the spleen, including an increase in the number and diameter of lymphoid follicles and the volume density of the white pulp. Destructive changes were detected in the livers of nontreated animals with B16 melanoma. Administration of isRNA in combination with dacarbazine did not cause any additional damage to liver parenchyma, while stimulating regenerative processes in hepatic tissue of tumor-bearing animals.


Subject(s)
Antineoplastic Agents, Alkylating/pharmacology , Dacarbazine/pharmacology , Melanoma, Experimental/drug therapy , RNA/pharmacology , Animals , Immunotherapy , Liver/drug effects , Mice , Spleen/immunology
3.
Mol Biol (Mosk) ; 54(1): 146-152, 2020.
Article in Russian | MEDLINE | ID: mdl-32163398

ABSTRACT

Migration of cancer cells from the primary tumor site to nearby tissues is the starting point of the metastatic process. The invasive properties of cells are especially important for carcinomas, since tumor cells need to overcome the basement membrane and go beyond its boundaries to the underlying tissues. Substances that reduce the invasive ability of malignant cells are promising as antimetastatic agents. In the present work, the possibility of inhibiting the ability of different cancer cell lines to migrate under the influence of the Bacillus pumilus ribonuclease (binase) was analyzed using the scratch-wound assay. It was established that binase at non-toxic concentrations (10 µg/mL) reliably suppressed the migratory ability of HuTu 80 human duodenum adenocarcinoma cells incubated with RNase for 48-72 h. The antimetastatic potential of binase is confirmed by molecular modeling data demonstrating the ability of binase to inhibit cellular metalloproteinases that determine the migration of tumor cells.


Subject(s)
Adenocarcinoma/enzymology , Adenocarcinoma/pathology , Cell Movement/drug effects , Duodenum/pathology , Ribonucleases/metabolism , Ribonucleases/pharmacology , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Humans , Metalloproteases/antagonists & inhibitors , Metalloproteases/metabolism
4.
Acta Naturae ; 11(3): 20-30, 2019.
Article in English | MEDLINE | ID: mdl-31720013

ABSTRACT

The development of novel drugs against the influenza virus with high efficiency and low toxicity is an urgent and important task. Previous reports have demonstrated that compounds based on sulfo derivatives of oligo- and polysaccharides possess high antiviral activity. In this study, we have examined the ability of a novel sulfonated derivative of ß-cyclodextrin (KS-6469) to inhibit the influenza virus A/WSN/33 (H1N1) infection in vitro and in vivo. The antiviral potential of KS-6469 against the influenza virus was evaluated in Madin-Darby Canine Kidney epithelial cells treated with serially diluted KS-6469. We found out that KS-6469 completely inhibited viral reproduction after treatment of the infected cells with the compound for 48 h. Our data show that double intranasal treatment of mice with KS-6469 fully protected the animals from a lethal infection and significantly decreased the viral titers in the lungs of the infected animals. Thus, the novel sulfonated ß-cyclodextrin derivative KS-6469 is a promising candidate for the development of antiviral drugs for preventing and treating the influenza infection.

5.
Proc Natl Acad Sci U S A ; 116(4): 1229-1234, 2019 01 22.
Article in English | MEDLINE | ID: mdl-30622178

ABSTRACT

Here we describe a DNA analog in which the mesyl (methanesulfonyl) phosphoramidate group is substituted for the natural phosphodiester group at each internucleotidic position. The oligomers show significant advantages over the often-used DNA phosphorothioates in RNA-binding affinity, nuclease stability, and specificity of their antisense action, which involves activation of cellular RNase H enzyme for hybridization-directed RNA cleavage. Biological activity of the oligonucleotide analog was demonstrated with respect to pro-oncogenic miR-21. A 22-nt anti-miR-21 mesyl phosphoramidate oligodeoxynucleotide specifically decreased the miR-21 level in melanoma B16 cells, induced apoptosis, reduced proliferation, and impeded migration of tumor cells, showing superiority over isosequential phosphorothioate oligodeoxynucleotide in the specificity of its biological effect. Lower overall toxicity compared with phosphorothioate and more efficient activation of RNase H are the key advantages of mesyl phosphoramidate oligonucleotides, which may represent a promising group of antisense therapeutic agents.


Subject(s)
Amides/metabolism , Oligonucleotides, Antisense/metabolism , Oligonucleotides/metabolism , Phosphates/metabolism , Phosphoric Acids/metabolism , Animals , Apoptosis/genetics , Cell Line, Tumor , Cell Movement/genetics , Cell Proliferation/genetics , DNA/metabolism , Melanoma, Experimental , Mice , MicroRNAs/metabolism , RNA/metabolism , Ribonuclease H/metabolism
6.
Sci Rep ; 8(1): 14990, 2018 10 09.
Article in English | MEDLINE | ID: mdl-30302012

ABSTRACT

Taking into account the important role of miRNA in carcinogenesis, oncogenic miRNAs are attractive molecules for gene-targeted therapy. Here, we developed a novel series of peptide-oligonucleotide conjugates exhibiting ribonuclease activity targeted to highly oncogenic miRNAs miR-21 and miR-17. When designing the conjugates, we enhanced both nuclease resistance of the targeted oligodeoxyribonucleotide by introducing at its 3'-end mini-hairpin structure displaying high thermostability and robustness against nuclease digestion and the efficiency of its functioning by attachment of the catalytic construction (amide)NH2-Gly(ArgLeu)4-TCAA displaying ribonuclease activity to its 5'-end. Designed miRNases efficiently cleaved miRNA targets, exhibiting Pyr-X specificity, and cleavage specificity had strong dependence on the miRNA sequence in the site of peptide location. In vitro, designed miRNases do not prevent cleavage of miRNA bound with the conjugate by RNase H, and more than an 11-fold enhancement of miRNA cleavage by the conjugate is observed in the presence of RNase H. In murine melanoma cells, miRNase silences mmu-miR-17 with very high efficiency as a result of miR-17 cleavage by miRNase and by recruited RNase H. Thus, miRNases provide a system of double attack of the miRNA molecules, significantly increasing the efficiency of miRNA downregulation in the cells in comparison with antisense oligonucleotide.


Subject(s)
Melanoma, Experimental/drug therapy , MicroRNAs/genetics , Ribonuclease H/genetics , Animals , Carcinogenesis/drug effects , Carcinogenesis/genetics , Cell Line, Tumor , Gene Silencing/drug effects , Humans , Melanoma, Experimental/genetics , Mice , MicroRNAs/antagonists & inhibitors , Oligodeoxyribonucleotides/chemical synthesis , Oligodeoxyribonucleotides/genetics , Oligodeoxyribonucleotides/pharmacology , Peptides/chemical synthesis , Peptides/genetics , Peptides/pharmacology , Pyrimidines/antagonists & inhibitors , Pyrimidines/metabolism , Substrate Specificity
7.
Mol Biol (Mosk) ; 52(2): 306-313, 2018.
Article in Russian | MEDLINE | ID: mdl-29695699

ABSTRACT

Due to wide spreading of inflammatory disease and imperfection of available anti-inflammatory drugs, mainly associated with their serious side effects, searching for new anti-inflammatory agents is a pressing problem. Natural triterpenoids and their synthetic analogs are a promising source of new drugs. In this study, we have investigated the anti-inflammatory and antitumor effects in vivo of the glycyrrhetinic acid derivative soloxolone methyl (SM), or methyl 2-cyano-3,12-dioxo-18ßH-olean-9(ll),l(2)-dien-30-oate. SM was shown to efficiently suppress the development of edema in a mouse model of carrageenan- or histamine-induced acute inflammation. SM also inhibited the tumor growth and reduced the tumor cell count in the ascitic fluid in mice bearing Krebs-2 carcinoma, the development of which is accompanied by an inflammatory process in the surrounding tissues.


Subject(s)
Carcinoma, Krebs 2/drug therapy , Glycyrrhetinic Acid , Animals , Carcinoma, Krebs 2/metabolism , Carcinoma, Krebs 2/pathology , Drug Screening Assays, Antitumor , Glycyrrhetinic Acid/analogs & derivatives , Glycyrrhetinic Acid/chemistry , Glycyrrhetinic Acid/pharmacology , Inflammation/drug therapy , Inflammation/metabolism , Inflammation/pathology , Male , Mice , Mice, Inbred ICR
8.
Acta Naturae ; 9(3): 27-38, 2017.
Article in English | MEDLINE | ID: mdl-29104773

ABSTRACT

The routine methods used to treat oncological diseases have a number of drawbacks, including non-specific action and severe side effects for patients. Furthermore, tumor diseases are associated with a suppression of the immune system that often leads to the inefficiency of standard treatment methods. The development of novel immunotherapeutic approaches having specific antitumor action and that activate the immune system is of crucial importance. Vaccines based on dendritic cells (DCs) loaded with tumor antigens ex vivo that can activate antitumor cytotoxic T-cell responses stand out among different antitumor immunotherapeutic approaches. This review is focused on analyzing different methods of DC-based vaccine preparation and current research in antitumor DC-based vaccines using animal tumor models and in clinical trials.

9.
Mol Biol (Mosk) ; 51(4): 637-646, 2017.
Article in Russian | MEDLINE | ID: mdl-28900082

ABSTRACT

After a long pause, the accumulation of data on the involvement of tumor-specific DNA and extracellular DNA in metastasis has again placed enzymes with deoxyribonuclease activity in the focus of the search for antitumor and antimetastatic drugs. In this work, the ability of bovine pancreatic DNase I to reduce the invasive potential of B16 melanoma has been investigated in vitro and in vivo. It was found that DNase I had a cytotoxic effect on B16 melanoma cells (IC50 ≈ 10^(4) U/mL). At the same time, significantly lower doses of DNase I (10^(2)-10^(3) U/mL) inhibited the migratory activity of melanoma cells in vitro, causing a decrease in the distance of cell front migration and in the area of scratch healing 48 h after the enzyme addition, as well as reducing the rate of cell migration. In mice with B16 metastatic melanoma, intramuscular administration of DNase I in the dose range of 0.12-1.20 mg/kg resulted in a two- to threefold decrease in the number of surface lung metastases and caused nonspecific antigenic immune stimulation.


Subject(s)
Antineoplastic Agents/pharmacology , Deoxyribonuclease I/pharmacology , Immunity, Innate/drug effects , Lung Neoplasms/drug therapy , Melanoma, Experimental/drug therapy , Skin Neoplasms/drug therapy , Animals , Antineoplastic Agents/isolation & purification , Cattle , Cell Movement/drug effects , Cell Survival/drug effects , Deoxyribonuclease I/isolation & purification , Female , Injections, Intramuscular , Lung Neoplasms/immunology , Lung Neoplasms/secondary , Melanoma, Experimental/immunology , Melanoma, Experimental/secondary , Mice , Mice, Inbred C57BL , Neoplasm Invasiveness , Pancreas/chemistry , Pancreas/enzymology , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Treatment Outcome
10.
Mol Biol (Mosk) ; 51(1): 118-125, 2017.
Article in Russian | MEDLINE | ID: mdl-28251974

ABSTRACT

The efficiency of the antitumor immune response triggered by dendritic cell (DC)-based vaccines depends predominantly on the efficiency of delivering tumor antigen-coding nucleic acids into DCs. Mannosylated liposomes were used to deliver tumor total RNA into DCs both ex vivo and in vivo, and the cytotoxic T-lymphocyte (CTL) antitumor response was assayed. The liposomes contained the mannosylated lipid conjugate 3-[6-(α-D-mannopyranosyloxy)hexyl]amino-4-{6-[rac-2,3-di(tetradecyloxy)prop-1-yl oxycarbonylamino]hexyl}aminocyclobut-3-en-1,2-dione), the polycationic lipid 2X3 (1,26-bis(cholest-5-en-3ß-yloxycarbonylamino)-7,11,16,20-tetraazahexacosane tetrahydrochloride), and the zwitterionic lipid DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) at a molar ratio of 1: 3: 6 and were used as a transfection agent. Total RNA isolated from B16-F10 mouse melanoma cells served as a source of tumor antigens. Systemic administration of mannosylated liposomes-tumor RNA complexes into circulation of melanoma-bearing mice induced an efficient CTL response, which reduced the melanoma cell index in vitro with the same efficiency (by a factor of 2.8) as CTLs activated via an inoculation of DCs loaded with complexes of the same composition ex vivo. Complexes of tumor RNA with control liposomes, which lacked the mannosylated lipid conjugate, or DCs transfected with these complexes ex vivo were less efficient and reduced the melanoma cell count by a factor of only 1.6-1.8.


Subject(s)
Antigens, Neoplasm/administration & dosage , Cancer Vaccines , Liposomes , RNA, Neoplasm/administration & dosage , T-Lymphocytes, Cytotoxic/immunology , Animals , Dendritic Cells , Melanoma, Experimental , Mice , Mice, Inbred C57BL , Transfection
11.
Acta Naturae ; 8(3): 17-30, 2016.
Article in English | MEDLINE | ID: mdl-27795841

ABSTRACT

Dendritic cells (DCs) play a crucial role in the initiation and regulation of the antitumor immune response. Already , DC-based antitumor vaccines have been thoroughly explored both in animal tumor models and in clinical trials. DC-based vaccines are commonly produced from DC progenitors isolated from peripheral blood or bone marrow by culturing in the presence of cytokines, followed by loading the DCs with tumor-specific antigens, such as DNA, RNA, viral vectors, or a tumor cell lysate. However, the efficacy of DC-based vaccines remains low. Undoubtedly, a deeper understanding of the molecular mechanisms by which DCs function would allow us to enhance the antitumor efficacy of DC-based vaccines in clinical applications. This review describes the origin and major subsets of mouse and human DCs, as well as the differences between them. The cellular mechanisms of presentation and cross-presentation of exogenous antigens by DCs to T cells are described. We discuss intracellular antigen processing in DCs, cross-dressing, and the acquisition of the antigen cross-presentation function. A particular section in the review describes the mechanisms of tumor escape from immune surveillance through the suppression of DCs functions.

12.
Mol Biol (Mosk) ; 50(1): 188-92, 2016.
Article in Russian | MEDLINE | ID: mdl-27028826

ABSTRACT

Human adenoviruses, in particular D8, D19, and D37, cause ocular infections. Currently, there is no available causally directed treatment, which efficiently counteracts adenoviral infectious diseases. In our previous work, we showed that gene silencing by means of RNA interference is an effective approach for downregulation of human species D adenoviruses replication. In this study, we compared the biological activity of siRNAs and their modified analogs targeting human species D adenoviruses DNA polymerase. We found that one of selectively 2'-O-methyl modified siRNAs mediates stable and long-lasting suppression of the target gene (12 days post transfection). We suppose that this siRNA can be used as a potential therapeutic agent against human species D adenoviruses.


Subject(s)
Adenoviruses, Human/drug effects , DNA-Directed DNA Polymerase/genetics , Down-Regulation/drug effects , RNA, Small Interfering/pharmacology , Adenovirus Infections, Human/drug therapy , Adenovirus Infections, Human/virology , Adenoviruses, Human/enzymology , Adenoviruses, Human/genetics , DNA-Directed DNA Polymerase/biosynthesis , Humans , RNA Interference , RNA, Small Interfering/therapeutic use , RNAi Therapeutics , Transfection
13.
Biochimie ; 101: 256-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24565811

ABSTRACT

The successful application of exogenous ribonucleases of different origin to suppress tumor growth allows one to consider them as perspective therapeutics for treatment of oncological diseases. An important aspect of the success of an anti-cancer drug is low hepatotoxicity, which will reduce, if not eliminate entirely the undesirable side effects of treatment. Previously we have shown that ribonuclease from Bacillus intermedius (binase) exhibits high antitumor and antimetastatic activity in tumor models of different histological origin. In this work we studied hepatotoxic action of binase using mouse tumor model of Lewis lung carcinoma. Binase at doses of 0.1-1 mg/kg which produced effective suppression of tumor growth and metastasis, showed positive effect on the liver of tumor-bearing mice expressed in a significant reduction in the volume of destructive changes in the liver parenchyma and return to the normal level of the liver regenerative potential impaired due to endogenous intoxication and tumor burden.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Lewis Lung/drug therapy , Endoribonucleases/pharmacology , Liver Regeneration/drug effects , Lung Neoplasms/drug therapy , Animals , Antineoplastic Agents/toxicity , Carcinoma, Lewis Lung/pathology , Endoribonucleases/toxicity , Female , Liver/drug effects , Liver/pathology , Liver/physiopathology , Lung Neoplasms/secondary , Mice, Inbred C57BL , Neoplasm Transplantation , Tumor Burden/drug effects , Xenograft Model Antitumor Assays
14.
Acta Naturae ; 6(4): 54-9, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25558395

ABSTRACT

Recombinant proteins represent a large sector of the biopharma market. Determination of the main elimination pathways raises the opportunities to significantly increase their half-lives in vivo. However, evaluation of biodegradation of pharmaceutical biopolymers performed in the course of pre-clinical studies is frequently complicated. Noninvasive pharmacokinetic and biodistribution studies in living organism are possible using proteins conjugated with near-infrared dyes. In the present study we designed a highly efficient probe based on fluorescent dye self-quenching for monitoring of in vivo biodegradation of recombinant human butyrylcholinesterase. The maximum enhancement of integral fluorescence in response to degradation of an intravenously administered enzyme was observed 6 h after injection. Importantly, excessive butyrylcholinesterase labeling with fluorescent dye results in significant changes in the pharmacokinetic properties of the obtained conjugate. This fact must be taken into consideration during future pharmacokinetic studies using in vivo bioimaging.

16.
Exp Oncol ; 35(1): 30-6, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23528313

ABSTRACT

AIM: Polychemotherapy (PCT), widely used for the antitumor treatment has a pronounced toxic effect on the organism, and its cytostatic effect sometimes is canceled by multidrug resistance of a neoplasia. Comprehension of the nature and development of pathological changes caused by the PCT during the treatment of cancer is very important to improve the efficiency of the therapy and to clarify the mechanisms of tumor-host interactions. This study was aimed to examine PCT impact on kidney cells and tissues in mice with transplanted resistant lymphosacroma (RLS) and to analyze morphology of metastases of the tumor in kidney during PCT. MATERIALS AND METHODS: Male mice CBA/LacSto (55 animals) were intramuscularly implanted in the right hind paw by 105 cells/ml of tumor RLS (a diffuse large B-cell lymphosarcoma) with multi-drug resistance (MDR) phenotype. Mice received combination of cyclophosphamide (50 mg/kg), oncovin (0.1 mg/kg), hydroxydaunorubicin (4 mg/kg), and prednisone (5 mg/kg) accordingly to CHOP scheme each 7 days after inoculation of the tumor. The kidneys were sampled on days 1, 3 and 7 after each series of injection of PCT preparations and processed for light and electron microscopy, immunohistochemical analysis of Ki-67 and Apaf-1 proteins also was performed. RESULTS: Tumor RLS produced metastases comprised of small cells in the kidneys of mice after 8 days post inoculation. Application of PCT resulted in destruction of small-cell metastases and development of many large-cell metastases in kidney. Application of PCT induced the development of prominent damage of nephron cells, primarily in S3 segments of proximal tubules. Even one series of PCT caused reduction of basal plasma folds in these cells and alteration of mitochondria. Damage of proximal tubules and involvement of distal tubules, renal bodies and interstitial tissue in the pathologic process, increased during the experiment. This work presents the description of morphological changes in kidney as well as of the tumor metastases under PCT influence. CONCLUSION: The obtained data should be considered while designing of remedies for recovery of internal organs functions after antitumor PCT.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Kidney Neoplasms/drug therapy , Kidney Tubules, Proximal/drug effects , Lymphoma, B-Cell/drug therapy , Nephrons/drug effects , Animals , Apoptotic Protease-Activating Factor 1/analysis , Cyclophosphamide/therapeutic use , Daunorubicin/analogs & derivatives , Daunorubicin/therapeutic use , Doxorubicin/therapeutic use , Ki-67 Antigen/analysis , Kidney/drug effects , Kidney/pathology , Kidney Neoplasms/secondary , Male , Mice , Mice, Inbred CBA , Mitochondria/drug effects , Neoplasm Transplantation , Prednisone/therapeutic use , Vincristine/therapeutic use
17.
Biochemistry (Mosc) ; 78(1): 1-7, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23379554

ABSTRACT

The term "exosomes" is currently used to describe specific vesicular structures of endosomal origin produced by the majority of eukaryotic cells. These natural vesicles have been under study for more than two decades. Nevertheless, a real splash of scientific interest in studies on exosomes took place only during recent years, when the concept of the role and functions of exosomes in multicellular organisms was essentially reconsidered. The major role in this was played by the discovery of exosomal mRNA and miRNA in 2007, which stimulated the idea of regulatory and communicative role of exosomes in the organism and also encouraged considering exosomes and other vesicles as potential biomarkers. The present review summarizes the up to date knowledge on the composition and probable physiological functions of nucleic acids released by different cells as components of exosomes. We also touch upon the problem of using these data in clinical diagnosis.


Subject(s)
Cell Adhesion Molecules/metabolism , Exosomes/metabolism , Nucleic Acids/metabolism , Animals , Biomarkers/analysis , Biomarkers/metabolism , Cell Adhesion Molecules/analysis , Cell Communication , Humans
19.
Bull Exp Biol Med ; 152(3): 348-52, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22803083

ABSTRACT

RLS lymphosarcoma characterized by enhanced expression of mdr1a and mdr1b genes encoding P-glycoprotein is insensitive to low doses of cyclophosphamide, but is susceptible to its high doses approximating the maximum tolerated doses. Induction of apoptotic death of RLS cells by high doses of cyclophosphamide was demonstrated by cytofluorometry and electrophoresis. Experiments on RLS(40) tumor cells derived from RLS lymphosarcoma and characterized by more intensive expression of mdr1a/1b genes showed that the therapeutic effects of cyclophosphamide increased under conditions of simultaneous suppression of these genes by specific small interfering RNA (siRNA). These findings suggest that active cyclophosphamide metabolite can be a substrate for P-glycoprotein.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Apoptosis/physiology , Cyclophosphamide/metabolism , Gene Expression Regulation, Neoplastic/physiology , Lymphoma, Non-Hodgkin/metabolism , ATP Binding Cassette Transporter, Subfamily B/metabolism , Animals , Apoptosis/drug effects , Cell Line, Tumor , Cyclophosphamide/pharmacology , Electrophoresis , Flow Cytometry , Gene Expression Regulation, Neoplastic/drug effects , Male , Mice , Mice, Inbred CBA , RNA, Small Interfering/genetics , ATP-Binding Cassette Sub-Family B Member 4
20.
FEBS Lett ; 586(11): 1669-73, 2012 Jun 04.
Article in English | MEDLINE | ID: mdl-22673577

ABSTRACT

Recent studies demonstrated the ability of artificial ribonucleases (aRNases, small organic RNA cleaving compounds) to inactivate RNA-viruses via the synergetic effect of viral RNA cleavage and disruption of viral envelope [1,2]. Herein, we describe the antiviral activity of aRNases against DNA-containing vaccinia virus: screening of aRNases of various structures revealed that amphiphilic compounds built of positively charged 1,4-diazabicyclo[2.2.2] octane substituted at the bridge nitrogen atoms with aliphatic residues efficiently inactivate this virus. The first stage was the destruction of viral membrane and structure of surface proteins (electron microscopy data). Thus, 1,4-diazabicyclo[2.2.2] octane-based aRNases are novel universal agents inactivating both RNA- and DNA-containing viruses.


Subject(s)
Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Biomimetic Materials/chemistry , Biomimetic Materials/pharmacology , Hydrophobic and Hydrophilic Interactions , Vaccinia virus/drug effects , Virus Inactivation/drug effects , Cell Line , Ribonucleases/metabolism , Time Factors , Vaccinia virus/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...